CVE-2016-8355
CriticalSummary
An issue was discovered in Smiths-Medical CADD-Solis Medication Safety Software (versions 1.0, 2.0, 3.0, and 3.1) that allows an authenticated user to gain elevated privileges on the SQL database. This enables modification of drug libraries, addition and deletion of users, and changes to user permissions.
Risk Assessment
Elevated privileges may lead to unauthorized changes in the system, posing risks to patient safety and data integrity.
Recommendation
It is recommended to restrict access to the software and regularly monitor and audit user permissions. Additionally, ensure that drug library updates are installed only by authorized personnel.
Original NVD description (English source)
An issue was discovered in Smiths-Medical CADD-Solis Medication Safety Software, Version 1.0; 2.0; 3.0; and 3.1. CADD-Solis Medication Safety Software grants an authenticated user elevated privileges on the SQL database, which would allow an authenticated user to modify drug libraries, add and delete users, and change user permissions. According to Smiths-Medical, physical access to the pump is required to install drug library updates.